Skip to content

    Oriental Aromatics Limited

    OAL
    Chemicals·29 May 2025
    Management Summary

    Oriental Aromatics reported strong financial performance for FY25 with significant growth in revenue, EBITDA, and PAT, driven by its fragrance division and strategic investments. Despite Q4 margin compression and initial losses from the new Mahad facility, the company is optimistic about future growth, focusing on value-added products and operational efficiencies. Management highlighted the strategic internalization of camphor brands and ongoing capacity expansions as key levers.

    Highlights

    5
    • FY25 Operating Revenue grew 11% YoY to ₹928 crores, demonstrating solid top-line expansion.

    • FY25 EBITDA nearly doubled to ₹93.4 crores, with EBITDA margins improving significantly to 10.06% from 5.62% in FY24.

    • Net profit after tax for FY25 surged to ₹34.3 crores, up from ₹9.1 crores in FY24, with PAT margins increasing by 260 basis points to 3.69%.

    • The fragrance division emerged as a key growth driver, securing new business internationally and domestically, and deepening engagement with existing clients.

    • The new greenfield Mahad facility for Evermoss commenced full commercial production, marking a significant milestone in capacity expansion and value-added product strategy.

    Concerns

    4
    • Q4 FY25 EBITDA margin compressed to 7.62% from 10.15% in the previous quarter, partly due to one-time sales promotion expenses and increased raw material prices.

    • The Mahad subsidiary incurred losses of ₹5.9 crores in Q4 and ₹11.74 crores for FY25 during its stabilization phase.

    • The camphor and terpene chemicals division faced a tough year with pricing pressure and oversupply, leading to subdued revenue from this segment.

    • Increased working capital and higher finance costs were noted due to a strategic build-up of inventories and extended payment terms from some marquee customers.

    What Changed2

    vs Q1 FY26

    Guidance items5 → 6 (+1)Risks discussed3 → 5 (+2)
    Key financials

    Metrics

    12

    Periods

    2

    Q4 FY25

    5
    • Operating Revenue
      ₹253 Cr
      YoY+17%QoQ+13.7%
    • EBITDA
      ₹19 Cr
    • EBITDA Margin
      7.6%
    • PAT
      ₹1.4 Cr
    • Mahad Subsidiary Loss
      ₹5.9 Cr

    FY25

    7
    • Operating Revenue
      ₹928 Cr
      YoY+11%
    • EBITDA
      ₹93.4 Cr
      YoY+98.7%
    • EBITDA Margin
      10.1%
    • PAT
      ₹34.3 Cr
      YoY+2.8%
    • Cash Profit
      ₹58 Cr
      YoY+100.7%

    Segment breakdown

    Camphor & Terpene Chemicals
    33% Revenue Contribution
    Specialty Aroma Ingredients
    33% Revenue Contribution
    Fragrance & Flavor
    33% Revenue Contribution
    List

    Capital allocation

    2
    high confidence
    CategoryHeadline
    Capex

    Capex disclosed

    Debt

    Debt disclosed

    Guidance & targets

    5
    CategoryTargetPriority
    Profitability
    EBITDA Margin
    10% to 12%
    Medium
    Profitability
    Gross Margin
    39%, 40% level
    High
    Profitability
    Mahad Plant Break-even
    Break-even
    High
    Capacity
    Mahad Plant Initial Capacity Utilization
    Sold out
    High
    Volume
    Volume Growth - Camphor
    Single-digit or steady
    Medium

    Mahad Plant Ramp-up & Break-even

    Coming quarters
    CurrentCommissioned, initial capacity 250 MT, Q4/FY25 losses
    TargetInitial capacity sold out, break-even

    Why it matters

    Verifies the successful commercialization and profitability of a major growth CAPEX investment.

    we are very confident that the current, that initial phase of production capacity that we have set out for which is 250 metric tons of this material, would be sold out in the coming quarters, and we will be able to break in.

    How to verify

    key_financials.metrics[label='Mahad Subsidiary Loss (Q4 FY25)']

    Risks & concerns

    5
    RiskSeverity

    Geopolitical uncertainties and trade policies

    Global uncertainty, geopolitical tensions, and changing trade relations pose risks and opportunities, impacting cross-border movement of raw materials and finished goods.Management acknowledged

    medium

    Raw material price volatility

    Inflationary pressures on petrochemicals, natural oils, and solvents earlier in the year squeezed margins, though easing by year-end.Management acknowledged

    medium

    Oversupply and competitive pricing in aroma chemicals and camphor

    New production capacities globally led to oversupply and competitive pricing, impacting profitability, especially in the camphor and terpene chemicals division.Management acknowledged

    high

    Indian FMCG sector slowdown

    Slowdown in H2, particularly urban demand, impacted the fragrance division, though the company managed to grow.Management acknowledged

    medium

    Increased working capital and finance costs

    Strategic inventory build-up and extended payment terms from marquee customers led to higher working capital and finance costs, though corrective steps are being taken.Management acknowledged

    medium

    Q&A highlights

    8

    “So primarily, we would like to be cautiously optimistic about the camphor division, we are seeing an uptick in terms of pricing, but the competitive landscape still remains in a situation where there is oversupply and the demand is growing, but is growing very steadily. So unless you do not have certain strategic levers, the ability to have sustainable profit margins is always going to be challenging.”

    Analyst sought specific guidance on margin improvement for a key segment, but management offered cautious optimism due to market dynamics.

    asked by Ankit Gupta

    3 min read7 chapters

    Detailed Narrative

    01

    Q4 & FY25 Financial Performance Overview

    Oriental Aromatics reported a strong FY25 with operating revenue of ₹928 crores, an 11% YoY increase. EBITDA nearly doubled to ₹93.4 crores, leading to a significant margin expansion to 10.06% from 5.62% in FY24. PAT also saw substantial growth, reaching ₹34.3 crores, up from ₹9.1 crores in the previous year. For Q4 FY25, operating revenue was ₹253 crores, growing 17% YoY and 13.7% QoQ, though EBITDA margin compressed to 7.62% from 10.15% in the prior quarter, partly due to one-time📎 expenses and raw material price increases.

    02

    Strategic Internalization of Camphor Brands

    The company highlighted the strategic internalization of its heritage brands, Saraswati camphor and 3 Pine camphor, which have been part of its portfolio for decades. This move, completed in FY25, means 60% of the manufactured camphor powder is now used internally. This provides a strategic moat, insulating the company from market pricing challenges and allowing for more efficient management and value realization compared to the previous franchise model.

    03

    Fragrance Division as a Key Growth Driver

    The fragrance division was a primary growth driver for the company in FY25, despite a slowdown in the Indian FMCG sector. Growth was achieved through winning new international and domestic clients, deepening engagement with existing customers, and expanding into new product lines. The company's backward integration, producing its own aroma ingredients, proved invaluable in ensuring supply, cost control, and competitive pricing for its fragrance compounds.

    04

    Camphor & Terpene Chemicals Division: Challenges and Stabilization

    The camphor and terpene chemicals division experienced a challenging year due to substantial drops in alpha pinene prices, overcapacity, and subdued demand, leading to pricing pressure and compressed margins. However, the company adopted a strategy of prioritizing profitability over volume, and market conditions began to stabilize in Q3 and Q4 FY25. The Bareli plant achieved improved operational efficiencies, contributing to a recovery in realization during the latter half of the fiscal year.

    05

    Specialty Aroma Ingredients & Mahad Plant Commissioning

    The specialty aroma ingredients division saw healthy demand and volume growth in FY25. A significant milestone was the commissioning of the new greenfield Mahad facility on November 12, 2024, dedicated to producing Evermoss, a specialized aroma ingredient. This plant, with an initial production capacity of 250 metric tons, is expected to be sold out in coming quarters and contribute to the company's top line and profitability in FY26 and beyond, with a projected turnover ratio of 1.4 to 1.5 times the investment.

    06

    Global Industry Landscape & Geopolitical Context

    Management noted the resilience of the fragrance and flavor industry globally, with robust demand for fine fragrances and essential consumer products. However, the sector faced headwinds from geopolitical uncertainties, trade policy shifts, and raw material price volatility. The company is actively monitoring and hedging against these risks, maintaining a diversified sourcing strategy to mitigate potential disruptions and remains optimistic about India's strong standing in the medium term.

    07

    Capital Allocation & Working Capital Strategy

    The company's debt levels increased in FY25, primarily due to long-term financing for the Baroda brownfield and Mahad greenfield projects. Working capital also rose due to a strategic decision to build inventories when aroma chemical and raw material prices were at their lowest, aiming to secure future supply and hedge against price increases. This led to higher finance costs, but management expects improvement as customer payments normalize and corrective steps are taken.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.